Concepedia

Publication | Open Access

Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma

DOIFull Paper Access

26

Citations

44

References

2023

Year

Lili Mao, Bin Lian, Caili Li, Xue Bai, Li Zhou, Chuanliang Cui, Zhihong Chi, Xinan Sheng, Xuan Wang, Bixia Tang,
JAMA Oncology

Abstract

ClinicalTrials.gov Identifier: NCT04397770.

References

YearCitations

Page 1